Spectral Diagnostics Return on Tangible Equity 2011-2025 | EDTXF
Current and historical return on tangible equity values for Spectral Diagnostics (EDTXF) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Spectral Diagnostics Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $-0.02B | $-0.03B | 60.61% |
| 2025-03-31 | $-0.02B | $-0.03B | 78.16% |
| 2024-12-31 | $-0.01B | $-0.02B | 58.67% |
| 2024-09-30 | $-0.02B | $-0.02B | 107.46% |
| 2024-06-30 | $-0.01B | $-0.02B | 107.69% |
| 2024-03-31 | $-0.01B | $-0.02B | 136.59% |
| 2023-12-31 | $-0.01B | $-0.01B | 165.52% |
| 2023-09-30 | $-0.01B | $-0.01B | 189.47% |
| 2023-06-30 | $-0.01B | $-0.01B | 228.57% |
| 2023-03-31 | $-0.01B | $0.00B | 311.11% |
| 2022-12-31 | $-0.01B | $0.00B | 800.00% |
| 2022-09-30 | $-0.01B | $0.00B | -3200.00% |
| 2022-06-30 | $-0.01B | $0.00B | -355.56% |
| 2022-03-31 | $-0.01B | $0.00B | -355.56% |
| 2021-12-31 | $-0.01B | $0.00B | -400.00% |
| 2021-09-30 | $0.75B | $0.01B | 100133.33% |
| 2021-06-30 | $0.75B | $0.00B | -300800.00% |
| 2021-03-31 | $-0.01B | $0.00B | -1000.00% |
| 2020-12-31 | $-0.01B | $0.00B | -1400.00% |
| 2020-09-30 | $-0.76B | $0.00B | -61120.00% |
| 2020-06-30 | $-0.76B | $0.00B | -43657.14% |
| 2020-03-31 | $-0.01B | $0.00B | -300.00% |
| 2019-12-31 | $0.00B | $0.00B | -133.33% |
| 2019-09-30 | $0.00B | $0.00B | -80.00% |
| 2019-06-30 | $0.00B | $0.00B | -75.00% |
| 2019-03-31 | $0.00B | $0.00B | -66.67% |
| 2018-12-31 | $0.00B | $0.01B | -75.00% |
| 2018-09-30 | $0.00B | $0.00B | -123.08% |
| 2018-06-30 | $0.00B | $0.01B | -145.45% |
| 2018-03-31 | $0.00B | $0.00B | -177.78% |
| 2017-12-31 | $0.00B | $0.00B | -145.45% |
| 2017-09-30 | $0.00B | $0.00B | -123.08% |
| 2017-06-30 | $-0.01B | $0.00B | -125.00% |
| 2017-03-31 | $-0.01B | $0.00B | -140.00% |
| 2016-12-31 | $-0.01B | $0.00B | -128.00% |
| 2016-09-30 | $-0.01B | $0.01B | -144.00% |
| 2016-06-30 | $-0.01B | $0.01B | -138.46% |
| 2016-03-31 | $-0.01B | $0.01B | -118.52% |
| 2015-12-31 | $-0.01B | $0.00B | -139.13% |
| 2015-09-30 | $-0.01B | $0.01B | -118.52% |
| 2015-06-30 | $-0.01B | $0.01B | -103.23% |
| 2015-03-31 | $-0.01B | $0.01B | -139.13% |
| 2014-12-31 | $-0.01B | $0.01B | -180.00% |
| 2014-09-30 | $-0.01B | $0.01B | -235.29% |
| 2014-06-30 | $-0.01B | $0.00B | -266.67% |
| 2014-03-31 | $-0.01B | $0.00B | -176.00% |
| 2013-12-31 | $-0.01B | $0.01B | -129.03% |
| 2013-09-30 | $-0.01B | $0.01B | -100.00% |
| 2013-06-30 | $-0.01B | $0.01B | -90.00% |
| 2013-03-31 | $-0.01B | $0.01B | -72.73% |
| 2012-12-31 | $-0.01B | $0.01B | -61.54% |
| 2012-09-30 | $-0.01B | $0.01B | -52.46% |
| 2012-06-30 | $-0.01B | $0.01B | -45.71% |
| 2012-03-31 | $-0.01B | $0.02B | -46.38% |
| 2011-12-31 | $-0.01B | $0.02B | -47.76% |
| 2011-09-30 | $-0.01B | $0.02B | -50.79% |
| 2011-06-30 | $-0.01B | $0.01B | -49.12% |
| 2011-03-31 | $-0.01B | $0.01B | -40.00% |
| 2010-12-31 | $-0.01B | $0.02B | -37.50% |
| 2010-09-30 | $-0.01B | $0.02B | -40.00% |
| 2010-06-30 | $0.00B | $0.02B | -43.24% |
| 2010-03-31 | $0.00B | $0.02B | -69.57% |
| 2009-12-31 | $0.00B | $0.00B | -114.29% |
| 2009-09-30 | $0.00B | $0.00B | -44.44% |
| 2009-06-30 | $0.00B | $0.00B | -40.00% |
| 2009-03-31 | $0.00B | $0.00B | 0.00% |
| 2008-12-31 | $0.00B | $0.00B | 0.00% |
| 2008-09-30 | $0.00B | $0.00B | -28.57% |
| 2008-06-30 | $0.00B | $0.00B | -26.67% |
| 2008-03-31 | $0.00B | $0.00B | -25.00% |
| 2007-12-31 | $0.00B | $0.00B | -25.00% |
| 2007-09-30 | $0.00B | $0.00B | 0.00% |
| 2007-06-30 | $0.00B | $0.00B | 200.00% |
| 2007-03-31 | $0.00B | $0.00B | 200.00% |
| 2006-09-30 | $0.00B | 0.00% | |
| 2006-06-30 | $0.00B | 0.00% | |
| 2005-12-31 | $-0.01B | -400.00% | |
| 2005-09-30 | $-0.01B | -400.00% | |
| 2005-06-30 | $-0.01B | -400.00% | |
| 2004-12-31 | $-0.01B | $0.01B | -600.00% |
| 2004-06-30 | $-0.01B | 500.00% | |
| 2003-12-31 | $0.00B | 600.00% | |
| 2003-06-30 | $0.00B | $0.00B | -1200.00% |
| 2003-03-31 | $0.00B | $0.00B | -300.00% |
| 2002-12-31 | $0.00B | $0.00B | -200.00% |
| 2002-09-30 | $-0.01B | $0.00B | -200.00% |
| 2002-06-30 | $-0.01B | $0.00B | -166.67% |
| 2002-03-31 | $0.00B | $0.00B | -80.00% |
| 2001-12-31 | $0.00B | $0.00B | -100.00% |
| 2001-09-30 | $0.00B | $0.01B | -75.00% |
| 2001-06-30 | $0.00B | $0.00B | -80.00% |
| 2001-03-31 | $-0.01B | $0.00B | -125.00% |
| 2000-12-31 | $0.00B | $0.00B | -66.67% |
| 2000-09-30 | $0.00B | $0.00B | 84.21% |
| 2000-06-30 | $0.00B | $0.01B | 57.14% |
| 2000-03-31 | $0.00B | $0.01B | 33.33% |
| 1999-12-31 | $0.00B | $0.01B | 28.57% |
| 1999-09-30 | $-0.01B | $0.01B | -121.74% |
| 1999-06-30 | $-0.01B | $0.01B | -164.71% |
| 1999-03-31 | $-0.01B | $0.01B | -311.11% |
| 1998-12-31 | $-0.01B | 0.00% | |
| 1998-09-30 | $-0.01B | 0.00% | |
| 1998-06-30 | $-0.01B | 0.00% | |
| 1998-03-31 | $-0.01B | 0.00% | |
| 1997-12-31 | $-0.01B | 0.00% | |
| 1997-09-30 | $-0.01B | 0.00% | |
| 1997-06-30 | $-0.01B | 0.00% | |
| 1997-03-31 | $-0.01B | 0.00% | |
| 1996-12-31 | $-0.01B | 0.00% | |
| 1996-09-30 | $-0.01B | 0.00% | |
| 1996-06-30 | $0.00B | 0.00% | |
| 1996-03-31 | $0.00B | 13.79% | |
| 1995-12-31 | $0.00B | 5.80% | |
| 1995-09-30 | $0.00B | 20.00% | |
| 1995-06-30 | $0.00B | $0.03B | -4.35% |
| 1994-06-30 | $-0.01B | $0.04B | -29.85% |
| 1994-03-31 | $0.00B | $0.01B | -53.33% |
| 1993-12-31 | $0.00B | $0.01B | -69.57% |
| 1993-09-30 | $0.00B | $0.00B | -80.00% |
| 1993-06-30 | $0.00B | $0.00B | -100.00% |
| 1993-03-31 | $0.00B | $0.00B | -123.08% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.294B | $0.002B |
| Spectral Medical Inc. develops and commercializes theranostic treatment for severe sepsis. The company's products include Endotoxin Activity Assay, a rapid diagnostic test for detection of components of gram negative bacterial cell wall; and Toraymyxin, a therapeutic hemoperfusion device for the treatment of sepsis that removes endotoxin from the bloodstream. Spectral Medical Inc., formerly known as Spectral Diagnostics Inc., is headquartered in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.059B | 25.55 |
| Intuitive Surgical (ISRG) | United States | $200.747B | 78.54 |
| IDEXX Laboratories (IDXX) | United States | $56.571B | 56.18 |
| Edwards Lifesciences (EW) | United States | $48.391B | 32.45 |
| Alcon (ALC) | Switzerland | $36.485B | 24.49 |
| IQVIA Holdings (IQV) | United States | $35.841B | 19.99 |
| Mettler-Toledo (MTD) | United States | $29.649B | 34.40 |
| STERIS (STE) | Ireland | $25.888B | 26.72 |
| Waters (WAT) | United States | $22.128B | 29.27 |
| DexCom (DXCM) | United States | $21.451B | 29.57 |
| Hologic (HOLX) | United States | $16.481B | 17.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.721B | 0.00 |
| Globus Medical (GMED) | United States | $11.330B | 23.57 |
| Penumbra (PEN) | United States | $10.425B | 73.33 |
| Masimo (MASI) | United States | $7.690B | 24.64 |
| Sysmex ADR (SSMXY) | Japan | $6.698B | 21.28 |
| Teleflex (TFX) | United States | $4.835B | 7.70 |
| Glaukos (GKOS) | United States | $4.816B | 0.00 |
| TransMedics (TMDX) | United States | $4.073B | 48.25 |
| Veracyte (VCYT) | United States | $3.296B | 37.57 |
| Alphatec Holdings (ATEC) | United States | $2.941B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.755B | 14.88 |
| Integer Holdings (ITGR) | United States | $2.392B | 11.23 |
| Artivion (AORT) | United States | $2.117B | 97.54 |
| Nihon Kohden (NHNKY) | Japan | $2.067B | 24.67 |
| PROCEPT BioRobotics (PRCT) | United States | $1.784B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.686B | 16.34 |
| Beta Bionics (BBNX) | United States | $1.158B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.099B | 0.00 |
| AxoGen (AXGN) | United States | $1.087B | 0.00 |
| IRadimed (IRMD) | United States | $1.073B | 51.11 |
| Pulse Biosciences (PLSE) | United States | $1.048B | 0.00 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.938B | 5.08 |
| SiBone (SIBN) | United States | $0.680B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.591B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.555B | 32.29 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.521B | 10.40 |
| AngioDynamics (ANGO) | United States | $0.495B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.449B | 0.00 |
| NeuroPace (NPCE) | United States | $0.437B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.427B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.418B | 11.59 |
| Semler Scientific (SMLR) | United States | $0.418B | 3.28 |
| RxSight (RXST) | United States | $0.385B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.327B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.305B | 50.82 |
| Sight Sciences (SGHT) | United States | $0.305B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.265B | 0.00 |
| CVRx (CVRX) | United States | $0.255B | 0.00 |
| Inogen (INGN) | United States | $0.189B | 0.00 |
| Neuronetics (STIM) | United States | $0.156B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.144B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| LENSAR (LNSR) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.084B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.077B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.060B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.038B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Envoy Medical (COCH) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.54 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |